Does SILTUXIMAB Cause Disease progression? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Disease progression have been filed in association with SILTUXIMAB (Sylvant). This represents 6.8% of all adverse event reports for SILTUXIMAB.
32
Reports of Disease progression with SILTUXIMAB
6.8%
of all SILTUXIMAB reports
17
Deaths
5
Hospitalizations
How Dangerous Is Disease progression From SILTUXIMAB?
Of the 32 reports, 17 (53.1%) resulted in death, 5 (15.6%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SILTUXIMAB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does SILTUXIMAB Cause?
Off label use (96)
Drug ineffective (72)
Immune effector cell-associated neurotoxicity syndrome (28)
Death (27)
Cytokine release syndrome (26)
Hypertension (24)
Product use in unapproved indication (24)
Drug effective for unapproved indication (23)
Cataract (19)
Condition aggravated (19)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which SILTUXIMAB Alternatives Have Lower Disease progression Risk?
SILTUXIMAB vs SILVER SULFADIAZINE
SILTUXIMAB vs SIMEPREVIR
SILTUXIMAB vs SIMPONI
SILTUXIMAB vs SIMVASTATIN
SILTUXIMAB vs SINGULAIR